Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Nash

Showing results (181-190 of 198) with videos related to

Pageof 20
Sort By:
Annals of the Rheumatic Diseases|January 28, 2021
Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trialBernard Combe, Alan Kivitz, Yoshiya Tanaka, et al.
International Journal of Rheumatic Diseases|September 4, 2015
APLAR rheumatoid arthritis treatment recommendationsChak Sing Lau, Faith Chia, Andrew Harrison, et al.
The Journal of Rheumatology|May 5, 2007
Consensus on a core set of domains for psoriatic arthritisDafna D Gladman, Philip J Mease, Vibeke Strand, et al.
The Journal of Rheumatology|October 13, 2009
Measures of response in clinical trials of systemic sclerosis: the Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS)Dinesh Khanna, Oliver Distler, Jerome Avouac, et al.
Therapeutic Advances in Musculoskeletal Disease|January 6, 2022
Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)Denis Poddubnyy, Xenofon Baraliakos, Filip Van den Bosch, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 2, 2017
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic ArthritisLaura C Coates, Oliver FitzGerald, Joseph F Merola, et al.
Annals of the Rheumatic Diseases|November 7, 2020
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statementPeter Nash, Andreas Kerschbaumer, Thomas Dörner, et al.
Annals of the Rheumatic Diseases|March 4, 2025
Expert consensus statement on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: 2024 updatePeter Nash, Andreas Kerschbaumer, Victoria Konzett, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 11, 2016
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic ArthritisLaura C Coates, Arthur Kavanaugh, Philip J Mease, et al.
Annals of the Rheumatic Diseases|July 17, 2012
The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project)Philip S Helliwell, Oliver FitzGerald, Jaap Fransen, et al.
Pageof 20

Showing results (181-190 of 198) with videos related to

Sort By:
Pageof 20
Annals of the Rheumatic Diseases|January 28, 2021
Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trialBernard Combe, Alan Kivitz, Yoshiya Tanaka, et al.
International Journal of Rheumatic Diseases|September 4, 2015
APLAR rheumatoid arthritis treatment recommendationsChak Sing Lau, Faith Chia, Andrew Harrison, et al.
The Journal of Rheumatology|May 5, 2007
Consensus on a core set of domains for psoriatic arthritisDafna D Gladman, Philip J Mease, Vibeke Strand, et al.
The Journal of Rheumatology|October 13, 2009
Measures of response in clinical trials of systemic sclerosis: the Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS)Dinesh Khanna, Oliver Distler, Jerome Avouac, et al.
Therapeutic Advances in Musculoskeletal Disease|January 6, 2022
Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)Denis Poddubnyy, Xenofon Baraliakos, Filip Van den Bosch, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 2, 2017
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic ArthritisLaura C Coates, Oliver FitzGerald, Joseph F Merola, et al.
Annals of the Rheumatic Diseases|November 7, 2020
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statementPeter Nash, Andreas Kerschbaumer, Thomas Dörner, et al.
Annals of the Rheumatic Diseases|March 4, 2025
Expert consensus statement on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: 2024 updatePeter Nash, Andreas Kerschbaumer, Victoria Konzett, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 11, 2016
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic ArthritisLaura C Coates, Arthur Kavanaugh, Philip J Mease, et al.
Annals of the Rheumatic Diseases|July 17, 2012
The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project)Philip S Helliwell, Oliver FitzGerald, Jaap Fransen, et al.
Pageof 20